Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ESMO 24: Pfizer To Take Cancer Weight Gain Drug Into Phase III

17 Sep 2024

• By Andrew McConaghie

Pfizer

Related Content

Pfizer Bullish On Danuglipron’s Position In Oral GLP-1 Race

30 Jul 2024

Related Companies

Pfizer Inc.

Additional Topics

Commercial Companies Clinical Trials Research & Development ESMO Cancer Hormonal Metabolic Disorders BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.